These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


127 related items for PubMed ID: 4906289

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Catecholamines.
    Axelrod J, Weinshilboum R.
    N Engl J Med; 1972 Aug 03; 287(5):237-42. PubMed ID: 4402575
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Pharmacology of the adrenergic system. II. Drug interference with the storage of catecholamines in and the release of catecholamines from the adrenergic system].
    Ariëns EJ.
    Pharm Weekbl; 1970 Aug 14; 105(33):885-95. PubMed ID: 4393664
    [No Abstract] [Full Text] [Related]

  • 6. The biosynthesis and metabolism of the catecholamines.
    Sandler M, Ruthven CR.
    Prog Med Chem; 1969 Aug 14; 6():200-65. PubMed ID: 4898078
    [No Abstract] [Full Text] [Related]

  • 7. Unnatural amino acids as precursors of false transmitters.
    Kopin IJ.
    Fed Proc; 1971 Aug 14; 30(3):904-7. PubMed ID: 4324976
    [No Abstract] [Full Text] [Related]

  • 8. CONCEPT OF THE NEUROCHEMICAL TRANSDUCER AS AN ORGANIZED MOLECULAR UNIT AT SYMPATHETIC NERVE ENDINGS.
    BRODIE BB, COSTA E.
    Act Nerv Super (Praha); 1963 Jul 14; 5():264-79. PubMed ID: 14055185
    [No Abstract] [Full Text] [Related]

  • 9. Changes in enzymes synthesizing catecholamines resulting from hypothalamic stimulation producing attack behavior in cat.
    Reis DJ, Moorhead DT, Rifkin M, Joh TH, Golstein M.
    Trans Am Neurol Assoc; 1970 Jul 14; 95():104-7. PubMed ID: 5535241
    [No Abstract] [Full Text] [Related]

  • 10. [The influencing of catecholamine liberation in nerve endings].
    Schönhöfer P.
    Schweiz Rundsch Med Prax; 1971 Jun 14; 60(26):867-70. PubMed ID: 5092314
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Biochemical aspects of release of norepinephrine and other amines from sympathetic nerve endings.
    Kopin IJ.
    Pharmacol Rev; 1966 Mar 14; 18(1):513-23. PubMed ID: 5904165
    [No Abstract] [Full Text] [Related]

  • 13. Ultrastructural cytochemistry and pharmacology of 5-hydroxytryptamine in adrenergic nerve endings. II. Accumulation of 5-hydroxytryptamine in nerve vesicles containing norepinephrine in rat vas deferens.
    Zieher LM, Jaim-Etcheverry G.
    J Pharmacol Exp Ther; 1971 Jul 14; 178(1):30-41. PubMed ID: 5087403
    [No Abstract] [Full Text] [Related]

  • 14. [Sympathetic nervous system and catecholamines in hypertension].
    Jäättelä A.
    Duodecim; 1974 Jul 14; 90(9):676-84. PubMed ID: 4608898
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Monoamine oxidase inhibitors and anesthesia].
    Iwatsuki K.
    Masui; 1969 Oct 14; 18(10):905-17. PubMed ID: 4901683
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Appearance and concentrations of catecholamines and their biosynthesis in the embryonic and developing chick.
    Ignarro LJ, Shideman FE.
    J Pharmacol Exp Ther; 1968 Jan 14; 159(1):38-48. PubMed ID: 5643949
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.